Axsome Therapeutics, Inc. (AXSM)

Thema bewerten
Beiträge: 3
Zugriffe: 5.270 / Heute: 1
Axsome Therapeu. 109,78 $ -1,69% Perf. seit Threadbeginn:   +2287,95%
 
Chalifmann3:

Axsome Therapeutics, Inc. (AXSM)

 
30.10.17 10:15
Top Chance auf Blockbuster ,hm ??!!

Werbung

Entdecke die beliebtesten ETFs von SPDR

SPDR MSCI Europe Financials UCITS ETF
Perf. 12M: +34,30%
SPDR MSCI Europe Communication Services UCITS ETF
Perf. 12M: +24,19%
SPDR S&P U.S. Utilities Select Sector UCITS ETF
Perf. 12M: +23,56%
SPDR MSCI World Financials UCITS ETF
Perf. 12M: +22,58%
SPDR MSCI World Utilities UCITS ETF
Perf. 12M: +21,18%

 
30.10.17 10:16
de.finance.yahoo.com/quote/AXSM/profile?p=AXSM

Axsome Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the management of central nervous system (CNS) disorders. The companyÂ’s product candidates include AXS-05 that is in Phase III trial for the treatment of treatment resistant depression and AlzheimerÂ’s disease agitation; and AXS-02, which is in Phase III trial to treat complex regional pain syndrome, knee osteoarthritis related to bone marrow lesions, and chronic low back pain related to Modic changes. It is also developing AXS-06, a preclinical product candidate for CNS disorders, including chronic pain. The company was founded in 2012 and is based in New York, New York.

Bewerten
 
09.03.20 13:14
hi leute,schaut mal was ich hier ausgegraben hab,bin leider nicht dabei .......

MFG
Chali
Bewerten
Es gibt keine neuen Beiträge.
 Ich: 


Hot-Stocks-Forum - Gesamtforum - Antwort einfügen - zum ersten Beitrag springen

Neueste Beiträge aus dem Axsome Therapeutics Inc Forum

Wertung Antworten Thema Verfasser letzter Verfasser letzter Beitrag
2 145 Axsome Therapeutics Mr. Gantzer Vassago 13.02.23 16:27
  2 Axsome Therapeutics, Inc. (AXSM) Chalifmann3 Chalifmann3 25.04.21 00:07